CEDEN Network Ltd and Kanpai Studios Announce the Successful Acquisition of Web3 Gaming Studio Raini Studios, Expanding Their Portfolio in the Digital Collectibles Space ROAD…
87% of people think the gifting season leads to wasteful behaviour. More than half of Europeans think that cost of living is their biggest concern…
Nearpay secures $14M in Series A funding, led by Sanabil Investments, with participation from stc Corporate Investment Fund, Vision Ventures, Hala Ventures and Arzan Ventures.…
The Company’s ESG strategy demonstrates its efforts to advance global health and environmental sustainability, as well as its commitments to employees and communities CAMBRIDGE, MA…
SAN DIEGO, CA / ACCESSWIRE / December 6, 2023 / Cognomovement, a pioneer in cognitive science-based wellness solutions, today announced the launch of CognoCravings, an…
Report Shows Visa Certifications Hitting a New High in 2023 But a Decline is Likely With U.S. Immigration Limits PHILADELPHIA, PA / ACCESSWIRE / December…
Revolutionizing Visual Experiences in Auto, Smartwatch, Smartphone, AR and VR. WATERLOO, ON / ACCESSWIRE / December 5, 2023 / VueReal celebrates a milestone in display…
BREAKFAST, in collaboration with HOFA Gallery and Art Miami, is set to unveil the highly anticipated ‘Flashbacks, Green Lines’ – an immersive kinetic installation at…
BluWave-ai EV Fleet Orchestrator shows 13% improvement in efficiency for COP28 Tesla taxi fleet connected via Smartcar’s vehicle API OTTAWA, ON / ACCESSWIRE / December…
CHICAGO, IL / ACCESSWIRE / December 4, 2023 / AELF announced today that it has welcomed Alexander “AJ” Issenman to the company as Director of…
Cloud security provider grows its platform with acquisition of Raftt, deepening platform support for shift-left initiatives NEW YORK, NY / ACCESSWIRE / December 4, 2023…
CGFNS International joins with The DAISY Foundation™ to honor outstanding nurse recruiters PHILADELPHIA, PA / ACCESSWIRE / November 17, 2023 / Foreign-educated nurses and other…
Cloud security provider announces new capabilities for securing AI, enabling customers to accelerate innovation while minimizing cloud risk NEW YORK, NY / ACCESSWIRE / November…
VILNIUS, LITHUANIA / ACCESSWIRE / November 16, 2023 / Northway Group is embarking on a project to establish Europe’s largest biotechnology hub, BIO CITY, in…
With EV Everywhere, Every Gigawatt Hour of Renewable Energy Diverted to Charging EVs Displaces 5.6 Million km Driven by Carbon-Emitting Vehicles OTTAWA, ON / ACCESSWIRE…
ZAGENO Recognized as a Trailblazer in the ProcureTech100 2023 Awards for its Revolutionary Marketplace CAMBRIDGE, MA / ACCESSWIRE / November 15, 2023 / ZAGENO Inc.,…
Graid Technology and ThinkParQ Join Forces to Redefine Benchmarks in High-Performance Computing, AI and Diverse Industries Reliant on Data-Intensive Operations SANTA CLARA, CA / ACCESSWIRE…
DUBAI, ARAB EMIRATES / ACCESSWIRE / November 12, 2023 / General Atomics Aeronautical Systems, Inc. (GA-ASI), a leading designer and manufacturer of proven, reliable Remotely…
WINCHESTER, ENGLAND / ACCESSWIRE / November 9, 2023 / Although biologically omnivores, dogs are often labelled as carnivores. Almost never are they considered vegetarians. Yet…
TORONTO, ON / ACCESSWIRE / November 9, 2023 / Andrew Enofe of Right at Home Realty Brokerage was featured in the Nationwide & International Edition…
Latest News
Australian researchers from Adelaide University and the Olivia Newton-John Cancer Research Institute have identified a novel molecular switch that drives the spread of aggressive tumors. Published in EMBO Molecular Medicine, the breakthrough study reveals that Australian researchers uncover a promising new way to tackle triple-negative breast cancer by restoring a critical regulatory molecule known as miR-342. The discovery opens new avenues to prevent life-threatening secondary cancers in organs such as the lungs and bones. Triple-negative breast cancer accounts for 10% to 15% of Australia’s approximately 21,000 annual breast cancer diagnoses but causes a disproportionate number of deaths. Lead investigators demonstrated that when miR-342 levels fall, a cancer-driving pathway called E2F becomes overactive, allowing dormant cancer cells to spread throughout the body and form dangerous secondary tumors.


